Article

Evidence-Based Quality Scores for Rating Drug Products and Their Utility in Health Systems

2020-05-26

Abstract excerpt

The quality of drug products in the United States, which are largely produced overseas, has been a matter of growing concern. 1 Buyers and payers of pharmaceuticals, whether they are health-systems, insurers, PBMs, pharmacies, physicians, or patients, have little to no visibility into any quality metrics for the manufacturers of drug products or the products themselves. A system of “quality scores” is proposed to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f460d02a-3023-5455-9bfb-1bf8685dea8b
DOI: 10.1101/2020.05.22.20110775

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evidence-Based Quality Scores for Rating Drug Products and Their Utility in Health SystemsDOI 10.1101/2020.05.22.20110775Read

Quantifying Fit-for-Purpose in Real World Data: Data Grading and FitQ ScoresSemantic proximity Read

Knowledge, Attitude and Practice on the Severity Classification of Adverse Drug Reactions From Reporting to Review: A Multicenter Cross-Sectional Study in ChinaSemantic proximity Read

Ensuring Quality Medicine: A Comprehensive Overview of EMA and DGDA's History, Structure, and Functions.Semantic proximity Read

How the HTAR will contribute to a value-based decision making for medicinal products across the EUSemantic proximity Read

DrugSet: A validated R Shiny application for reproducible drug codelist construction from ATC classification to CPRD Aurum prodcodesSemantic proximity Read

Deficiency Patterns in FDA Complete Response Letters for New Drug and Biologics Applications: A Cross-Sectional AnalysisSemantic proximity Read

Beyond QTPP: Introducing the Quality Target Administration (QTAP) Profile for Enteral Feeding Tube MedicationsSemantic proximity Read

Similarity and Consistency Assessment of Three Major Online Drug-Drug Interaction ResourcesSemantic proximity Read

Evidence-based indicators for the measurement of quality of primary care using health insurance claims data in Switzerland: update of the SQUIPRICA working groupSemantic proximity Read

A Decision Support System for Preclinical Assessment of Nanomaterials in Medical Products: The REFINE DSSSemantic proximity Read

An intelligent algorithm based on weighted similarity distances for multiple contributing prescription recognition: SIAPSemantic proximity Read

Algorithmic Opacity in Opioid Risk Scoring and the Need for Transparent AI RegulationSemantic proximity Read